SCOLR Pharma, Inc. (SCLR) - Financial and Strategic SWOT Analysis Review
SCOLR Pharma, Inc. (SCOLR) is a pharmaceutical company that is engaged in the development of extended release solid oral pharmaceutical medications and nutritional supplements with the help of its Controlled Delivery Technology (CDT). The company has developed CDT that enables control over the timing and amount on the release of active ingredients. It is capable to provide near zero order kinetics over 24 hours. Its product portfolio consists of analgesic, cardiovascular, diabetes, anti-nausea, and pulmonary products; and dietary supplement products, including combinations of glucosamine and chondroitin, calcium, and other dietary products. The pipeline lead products of the company include Ibuprofen and Pseudoephedrine. The company markets its dietary supplement products through private label retailers in the US and provide pharmaceutical and OTC products and services internationally through partners. SCOLR is headquartered in Bothell, the US.
SCOLR Pharma, Inc. Key Recent Developments
Jul 26, 2011 SCOLR Pharma Reports Q2 2011 Results May 09, 2011 SCOLR Pharma Reports Net Loss Of $1.2m For Q1 2011 Mar 29, 2011 SCOLR Reports Net Loss Of $3.2m For 2010 Jan 13, 2011 SCOLR Common Stock To Begin Trading On OTC Bulletin Board And OTCQB Stock Market Dec 22, 2010 SCOLR Pharma Announces Intention To Voluntarily Delist From NYSE AMEX Exchange
This comprehensive SWOT profile of SCOLR Pharma, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities - A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.